Timothy A. Springer



Timothy Springer is an internationally recognized leader in structural biology and immunology. With over 500 peer-reviewed publications that have received over 90,000 citations, he is one of the most highly cited scientists in any field. Timothy Springer received his Ph.D. from Harvard University in 1976, and subsequent post-doctoral training with Dr. Cesar Milstein in Cambridge, UK. Timothy Springer has been elected to the National Academy of Sciences and to the American Academy of Arts and Sciences. Among numerous awards and honors, Timothy Springer is a recipient of the Royal Society of Medicine Medal, the William B. Coley Medal from the Cancer Research Institute, and the Crafoord Prize from the Swedish Academy of Sciences. Timothy Springer's research laid the foundation for a new class of pharmaceuticals, the selective adhesion molecule inhibitors, which include the approved drugs, alefacept, efalizumab, and natalizumab. Timothy Springer was the Founder of LeukoSite, a biotechnology company acquired by Millennium Pharmaceuticals in 1999. LeukoSite developed therapeutics for inflammatory, autoimmune, and cancer applications, including FDA-approved Campathâ„¢.

Want to contact Timothy A. Springer?

Feel free to contact us to make you prepared.


Timothy Springer is an internationally recognized leader in structural biology and immunology. With over 500 peer-reviewed publications that...

Number of Registered Investments:9

Contact Details:

Location:Cambridge, Massachusetts, United States

Email is Not Provided

Phone Number:Cambridge, Massachusetts, United States

Updated August 2023. This content was crafted by an associate of Najafi Capital (“Najafi”) and is presented strictly for informational objectives. The details on this page neither advocate for nor dissuade the subscription, acquisition, or sale of any security or offering. The material Najafi evaluates for project owner screening and due diligence stems directly from the project owner presenting the investment opportunity. While Najafi perceives the information to have been sourced from trustworthy channels, there is no absolute assurance, warranty, or representation concerning its authenticity. Najafi renounces any liability regarding content provided by the project owner, inclusive of the data utilized to fulfill elements outlined on this page. Najafi is not accountable for the precision, legality, or the affirmation of subsequent details shared by the project owner.

Prospective investors are urged to perform their individual due diligence and authenticate the provided data. Investing inherently encompasses risks, inclusive of the potential loss of capital invested. All investors are recommended to ponder over these aspects in tandem with a chosen professional consultant to ascertain the suitability of an investment.

Investment Finder Wizard

Investment Finder Wizard

Powered by Google GemniAI, Controlled by Experts

What is your main goal for Investment?

Investment Size

In which Industry?

Which Countries do you prefer?

You can either specify the region or describe it with terms like "Germanic countries", "Countries with Mild Weather",...

Your tailored investment plan is on the way!

Soon, our team will analyze your investment goals and preferences to provide you with a comprehensive report outlining the ideal jurisdictions, investment strategies, and potential opportunities aligned with your selected industries. Stay tuned for insightful guidance tailored to your specific needs.